Ethyl benzo[d]thiazole-5-carboxylate, 95.0%, 250mg

8-(2,3-dichlorophenyl)-8-oxooctanoic acid, 97.0%, 2g

Matraces de fondo redondo con doble cuello, 2000 ml, 29/32, 19/26, 1 Pieza

8-Bromo-5-chloro-2-(trifluoromethyl)-1,6-naphthyridine, 95.0%, 1g

8-Bromo-2-methyl-4,5-dihydronaphtho[1,2-d]oxazole, 97%, 1g

(2-amino-4-chlorophenyl)(phenyl)methanol, 95.0%, 250mg

Polydimethylsiloxanes, trimethylsiloxy terminated cSt 2,500,000, 3.5kg

Ethyl 5-Nitroindole-2-carboxylate>98.0%(GC)1g

Methyl 2-chloroacetimidate hydrochloride, 97%, 5g

N,N,N',N'-Tetrakis[4-(diisobutylamino)phenyl]-1,4-phenylenediamine>98.0%(T)5g

tert-Butyl (2-bromo-4-nitrophenyl)carbamate, 98%, 1g

N-(Azetidin-3-yl)methanesulfonamide hydrochloride, 95.0%, 25g

Matraces de fondo plano 50 ml NS 19/26